Corrigendum to:: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)

Ulf Landmesser; M. John Chapman; Jane K. Stock; Pierre Amarenco; Jill Belch; Jan Borén; Michel Farnier; Brian A. Ference; Stephan Gielen; Ian Graham; Diederick E. Grobbee; G. Kees Hovingh; Thomas F. Luscher; Massimo Piepoli; Kausik K. Ray; Erik S. Stroes; Olov Wiklund; Stephan Windecker; Jose Luis Zamorano; Fausto Pinto; Lale Tokgozoglu; Jeroen J. Bax; Alberico L. Catapano

doi:10.1093/eurheartj/ehx648

Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)

Ulf Landmesser, M. John Chapman, Jane K. Stock, Pierre Amarenco, Jill Belch, Jan Borén, Michel Farnier, Brian A. Ference, Stephan Gielen, Ian Graham, Diederick E. Grobbee, G. Kees Hovingh, Thomas F. Luscher, Massimo Piepoli, Kausik K. Ray, Erik S. Stroes, Olov Wiklund, Stephan Windecker, Jose Luis Zamorano, Fausto PintoLale Tokgozoglu, Jeroen J. Bax, Alberico L. Catapano

Molecular and Clinical Medicine

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Original language	English
Article number	ehx648
Pages (from-to)	1-1
Number of pages	1
Journal	European Heart Journal
DOIs	https://doi.org/10.1093/eurheartj/ehx648
Publication status	Published - 24 Nov 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/eurheartj/ehx648

2 Citations
1 Comment/debate

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J. J. F., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., Grobbee, D. E., Hovingh, G. K., Luscher, T. F., Piepoli, M. F., Ray, K. K., Stroes, E. S., Wiklund, O., Windecker, S., Zamorano, J. L., Pinto, F., & 3 othersTokgozoglu, L., Bax, J. J. & Catapano, A. L., 7 Apr 2018, In: European Heart Journal. 39, 14, p. 1131-1143 13 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
File
175 Citations (Scopus)

133 Downloads (Pure)

Cite this

Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., Grobbee, D. E., Hovingh, G. K., Luscher, T. F., Piepoli, M., Ray, K. K., Stroes, E. S., Wiklund, O., Windecker, S., Zamorano, J. L., ... Catapano, A. L. (2017). Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017). European Heart Journal, 1-1. Article ehx648. https://doi.org/10.1093/eurheartj/ehx648

@article{7c8c82af022843a8890a7e3cefc0d111,

title = "Corrigendum to:: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)",

author = "Ulf Landmesser and Chapman, {M. John} and Stock, {Jane K.} and Pierre Amarenco and Jill Belch and Jan Bor{\'e}n and Michel Farnier and Ference, {Brian A.} and Stephan Gielen and Ian Graham and Grobbee, {Diederick E.} and Hovingh, {G. Kees} and Luscher, {Thomas F.} and Massimo Piepoli and Ray, {Kausik K.} and Stroes, {Erik S.} and Olov Wiklund and Stephan Windecker and Zamorano, {Jose Luis} and Fausto Pinto and Lale Tokgozoglu and Bax, {Jeroen J.} and Catapano, {Alberico L.}",

year = "2017",

month = nov,

day = "24",

doi = "10.1093/eurheartj/ehx648",

language = "English",

pages = "1--1",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

}

Landmesser, U, Chapman, MJ, Stock, JK, Amarenco, P, Belch, J, Borén, J, Farnier, M, Ference, BA, Gielen, S, Graham, I, Grobbee, DE, Hovingh, GK, Luscher, TF, Piepoli, M, Ray, KK, Stroes, ES, Wiklund, O, Windecker, S, Zamorano, JL, Pinto, F, Tokgozoglu, L, Bax, JJ & Catapano, AL 2017, 'Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)', European Heart Journal, pp. 1-1. https://doi.org/10.1093/eurheartj/ehx648

Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017). / Landmesser, Ulf; Chapman, M. John; Stock, Jane K. et al.
In: European Heart Journal, 24.11.2017, p. 1-1.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Corrigendum to:

T2 - 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)

AU - Landmesser, Ulf

AU - Chapman, M. John

AU - Stock, Jane K.

AU - Amarenco, Pierre

AU - Belch, Jill

AU - Borén, Jan

AU - Farnier, Michel

AU - Ference, Brian A.

AU - Gielen, Stephan

AU - Graham, Ian

AU - Grobbee, Diederick E.

AU - Hovingh, G. Kees

AU - Luscher, Thomas F.

AU - Piepoli, Massimo

AU - Ray, Kausik K.

AU - Stroes, Erik S.

AU - Wiklund, Olov

AU - Windecker, Stephan

AU - Zamorano, Jose Luis

AU - Pinto, Fausto

AU - Tokgozoglu, Lale

AU - Bax, Jeroen J.

AU - Catapano, Alberico L.

PY - 2017/11/24

Y1 - 2017/11/24

U2 - 10.1093/eurheartj/ehx648

DO - 10.1093/eurheartj/ehx648

M3 - Article

SN - 0195-668X

SP - 1

EP - 1

JO - European Heart Journal

JF - European Heart Journal

M1 - ehx648

ER -

Landmesser U, Chapman MJ, Stock JK, Amarenco P, Belch J, Borén J et al. Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017). European Heart Journal. 2017 Nov 24;1-1. ehx648. doi: 10.1093/eurheartj/ehx648